Does a Genetic Risk Score for Waist-to-Hip Ratio Confirm Relationship to Diabetes and Heart Disease?
BACKGROUND AND PURPOSE:
Observational studies demonstrate an association between waist-to-hip ratio (WHR), type 2 diabetes and coronary heart disease
Evidence still lacking as to whether this is a truly a causal relationship or associative
Genetic variants are randomly assorted and determined at conception and would therefore be less likely to be affected by common biases seen in observational studies
Emdin et al. (JAMA, 2018) sought to determine if genetic evidence could be used to help establish causality by developing a genetic risk score for abdominal adiposity in relationship to diabetes/ coronary heart disease
A polygenic risk score for WHR, adjusted for BMI, was constructed with 48 SNPs
A mendelian randomization analysis that combined case-control and cross-sectional data sets was used to test the strength of the association between the polygenic risk score and different cardiometabolic traits, coronary heart disease and type 2 diabetes
Is an epidemiologic methodology that uses genetic variation in known genes to help establish causality of a modifiable exposure on disease (in this case, diabetes and coronary heart disease) previously seen in observational studies
Mendelian randomization analysis requires genetic variants to be associated with the exposure of interest, not be associated with confounders and not associated with outcome independently of the exposure
Estimated cardiometabolic traits were based on data from 4 genome-wide association studies
Estimates for type 2 diabetes and coronary heart disease were based on 2 separate genome-wide association studies
The primary outcomes were Type 2 diabetes and coronary heart disease
Blood lipids, blood pressure, and glycemic phenotypes were used as potential intermediates for these disorders
Data was collected form 111,986 individuals (mean age = 57; 53.5% women)
1 standard deviation increase in WHR adjusted for BMI mediated by the polygenic risk score was associated with (P<0.001 for each)
27 mg/dL higher triglyceride levels
4.1 mg/dL higher 2-hour glucose levels
2.1 mm Hg higher systolic blood pressure
1 standard deviation increase in WHR adjusted for BMI was also associated with
Higher risk for type 2 diabetes odds ratio (OR) 1.77 (95% Cl, 2.57-2.00)
Higher risk for coronary heart disease OR 1.46 (95% Cl, 1.3-2.4)
A genetic predisposition to higher WHR adjusted for BMI was associated with an increased risk of type 2 diabetes and coronary heart disease
This study supports a causal relationship between abdominal adiposity and type 2 diabetes and coronary heart disease
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan